BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7482446)

  • 1. Activating effect of the plasminogen activators on plasminogens of different mammalia species.
    Yakovlev SA; Rublenko MV; Izdepsky VI; Makogonenko EM
    Thromb Res; 1995 Aug; 79(4):423-8. PubMed ID: 7482446
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative activation kinetics of mammalian plasminogens.
    Wohl RC; Sinio L; Summaria L; Robbins KC
    Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of individual caseins on plasminogen activation by bovine urokinase-type and tissue-type plasminogen activators.
    Politis I; White JH; Zavizion B; Goldberg JJ; Guo MR; Kindstedt P
    J Dairy Sci; 1995 Mar; 78(3):484-90. PubMed ID: 7782505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
    Lijnen HR; Stump DC; Collen DC
    Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
    Shatos MA; Doherty JM; Penar PL; Sobel BE
    Circulation; 1996 Aug; 94(4):636-42. PubMed ID: 8772682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
    Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
    Gao SW; Morser J; McLean K; Shuman MA
    Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of synergism between tissue-type plasminogen activator and urokinase on plasminogen activation rate in plasma.
    Rydzewski A; Takada Y; Takada A
    Thromb Res; 1989 Mar; 53(6):577-83. PubMed ID: 2499946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The search for the ideal thrombolytic agent.
    Verstraete M
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ultrasound on enzymatic activity of selected plasminogen activators.
    Soltani A; Soliday C
    Thromb Res; 2007; 119(2):223-8. PubMed ID: 16545433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New thrombolytic agents].
    Okada K
    Rinsho Byori; 1992 Mar; Suppl 92():115-30. PubMed ID: 1583770
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
    Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acyl-enzymes and pro-urokinase: promising new thrombolytic agents.
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 3():33-7. PubMed ID: 3095196
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the urokinase and streptokinase activation properties of the native and lower molecular weight forms of sheep plasminogen.
    Paoni NF; Castellino FJ
    J Biol Chem; 1979 Mar; 254(6):2064-70. PubMed ID: 154519
    [No Abstract]   [Full Text] [Related]  

  • 15. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system.
    Mattsson C; Nyberg-Arrhenius V; Wallén P
    Thromb Res; 1981 Mar; 21(6):535-45. PubMed ID: 7022741
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular mechanisms of thrombolytic therapy].
    Lijnen HR; Collen D
    Haemostasis; 1986; 16 Suppl 4():3-15. PubMed ID: 2945768
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 18. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
    Thorsen S
    Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of novel thrombolytic agents.
    Collen D; De Bono DP; Lijnen HR; Pannekoek H
    J Intern Med; 1994 Oct; 236(4):433-7. PubMed ID: 7931045
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.